Bcl-2 |
124 |
Dako-Cytomation |
1 : 100 |
Cytoplasm |
% of positive cells |
>10% (positive) |
Antigen retrieval microwave |
Normal breast acini |
Omitting the antibody |
BRCA1 |
Ab-1 (MS110) |
Calbiochem |
1 : 150 |
Nuclear |
% of positive cells |
<25% (negative)
|
Antigen retrieval microwave |
MCF 7 cells |
Omitting the antibody |
Ck5/6 |
M7237 |
Dako-Cytomation |
1 : 60 |
Cytoplasm |
% of positive cells |
≥10% (positive) |
Antigen retrieval microwave |
Known case of CK56 BC |
Omitting the antibody |
E-cadherin |
NCH-38 |
Dako-Cytomation |
1 : 100 |
Cytoplasm and membrane |
% of positive cells |
≥100 H score (positive) |
Antigen retrieval microwave |
Normal gastric mucosa |
Omitting the antibody |
EGFR |
31G7 |
Novocastra |
1 : 30 |
Membrane |
% of positive cells |
≥10% (positive) |
Not required |
Myoepithelial cells of normal duct in normal mammary gland |
Omitting the antibody |
erbB2 |
Polyclonal |
Dako-Cytomation |
1 : 100 |
Membrane |
Table 2.1 |
Table 2.1 |
Not required |
Known case of erbB2 strong BC expression |
Omitting the antibody |
ER |
1D5 |
Dako-Cytomation |
1 : 200 |
Nuclear |
% of positive cells |
≥0 (positive) |
Antigen retrieval microwave |
Normal breast acini |
Omitting the antibody |
Ki-67 |
MIB1 |
Dako-Cytomation |
1 : 25 |
Nuclear |
% of positive cells |
<10% (low)
|
Antigen retrieval microwave |
Human tonsil tissue |
Omitting the antibody |
P-cadherin |
NCL-P-cad
|
Novocastra
|
1 : 200 |
Cytoplasm |
% of positive cells |
≥5% (positive) |
Antigen retrieval microwave |
Known case of P-cadherin strong BC expression |
Omitting the antibody |
PgR |
PgR |
Dako-Cytomation |
1 : 150 |
Nuclear |
% of positive cells |
≥0 (positive) |
Antigen retrieval microwave |
Normal breast acini |
Omitting the antibody |
p21 |
EA10 |
Abcam |
1 : 25 |
Nuclear |
% of positive cells |
≥10% (positive) |
Antigen retrieval microwave |
Normal breast acini |
Omitting the antibody |
p53 |
DO7 |
Novocastra |
1 : 50 |
Nuclear |
% of positive cells |
>10% (negative)
|
Antigen retrieval microwave |
Normal breast acini |
Omitting the antibody |